CD300C and Alzheimer disease: Here, we have observed that basophils from patients with moderate-to-severe AD infants exhibited a marked reduction in the expression of CD300a and a slightly higher expression of CD300c than healthy controls, suggesting that these basophils have a more activating profile, reminiscent of basophils from allergic individuals.